HL-339 Camidanlumab Tesirine: Updated Efficacy and Safety in an Open-Label, Multicenter, Phase 2 Study of Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (R/R cHL)

Carlo-Stella, Carmelo; Ansell, Stephen; Zinzani, Pier Luigi; Radford, John; Maddocks, Kami; Pinto, Antonio; Collins, Graham P.; Bachanova, Veronika; Bartlett, Nancy; Bence-Bruckler, Isabelle; Hamadani, Mehdi; Kline, Justin; Mayer, Jiri; Savage, Kerry J.; Advani, Ranjana; Calmi, Paolo; Casasnovas, René-Olivier; Feldman, Tatyana; Hess, Brian; Bastos-Oreiro, Mariana; Iyengar, Sunil; Eisen, Sandy; Negievich, Yanina; Wang, Luqiang; Wuerthner, Jens; Herrera, Alex F.